![Pi Network [IOU] 가격](/uploads/mini-coins/pi-network-iou.jpg?1739401495)
결과 페이지 2 - 국가: 독일 부문: 보건의료 업종: 생명공학 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
독일 (738)
모든 거래소
- {{item.name}}
- 모든 거래소
- Dusseldorf (1)
- Frankfurt (648)
- Munich (27)
- Stuttgart (39)
- XETRA (23)
보건의료 (738)
- {{item.name}}
- 모든 업종
- 보건의료 (738)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Merus N.V. 2GH.F | $42.4 46.35 USD |
+1.44
|
$3.09B 3.38B USD | $300 327.94 USD | $42.4 46.35 USD | $44.6 48.75 USD | $3.09B 3.38B USD | 0 | -$3.22 -3.5 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $23.48 25.67 USD |
-13.61
|
$2.92B 3.19B USD | $10 10.93 USD | $23.48 25.67 USD | $23.48 25.67 USD | $2.92B 3.19B USD | 0 | -$1.54 -1.6 USD | |
| Viking Therapeutics, Inc. 1VT.F | $24.73 27.03 USD |
-11.36
|
$2.78B 3.03B USD | $175 191.3 USD | $24 26.24 USD | $26.95 29.46 USD | $2.78B 3.03B USD | 0 | -$0.97 -1.06 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $53.25 58.21 USD |
-0.56
|
$2.76B 3.02B USD | $175 191.3 USD | $53.25 58.21 USD | $53.25 58.21 USD | $2.76B 3.02B USD | 19.94 | $2.67 2.92 USD | |
| Amicus Therapeutics, Inc. AM6.F | $8.95 9.78 USD |
+2.29
|
$2.75B 3.01B USD | $73 79.8 USD | $8.95 9.78 USD | $8.95 9.78 USD | $2.75B 3.01B USD | 0 | -$0.17 -0.1 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $35.4 38.7 USD |
-3.8
|
$2.71B 2.96B USD | $100 109.31 USD | $35.4 38.7 USD | $35.4 38.7 USD | $2.71B 2.96B USD | 0 | -$2.9 -3.1 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $22.07 24.13 USD |
+7.45
|
$2.69B 2.95B USD | $55 60.12 USD | $21.69 23.71 USD | $22.07 24.13 USD | $2.69B 2.95B USD | 17.51 | $1.26 1.38 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| Veracyte, Inc. 12V.F | $33.2 36.29 USD |
+3.11
|
$2.58B 2.82B USD | $30 32.79 USD | $33.2 36.29 USD | $33.2 36.29 USD | $2.58B 2.82B USD | 110.66 | $0.3 0.33 USD | |
| Denali Therapeutics Inc. 4DN.F | $15.84 17.32 USD |
-0.5
|
$2.56B 2.8B USD | $45 49.19 USD | $15.84 17.32 USD | $15.84 17.32 USD | $2.56B 2.8B USD | 0 | -$2.47 -2.7 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| Vericel Corporation ATQP.F | $49 53.56 USD |
+3.38
|
$2.45B 2.68B USD | $135 147.57 USD | $49 53.56 USD | $49 53.56 USD | $2.45B 2.68B USD | 257.89 | $0.19 0.21 USD | |
| Denali Therapeutics Inc. 4DN.MU | $16.26 17.77 USD |
-10.04
|
$2.34B 2.56B USD | $0 0 USD | $16.26 17.77 USD | $16.26 17.77 USD | $2.34B 2.56B USD | 0 | -$2.47 -2.7 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $18.06 19.74 USD |
-0.17
|
$2.28B 2.49B USD | $170 185.83 USD | $18.06 19.74 USD | $18.06 19.74 USD | $2.28B 2.49B USD | 0 | -$4.95 -5.4 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $44.4 48.54 USD |
0
|
$2.2B 2.4B USD | $43 47 USD | $44.2 48.32 USD | $44.4 48.54 USD | $2.2B 2.4B USD | 0 | -$1.78 -1.9 USD | |
| BB Biotech AG Ord BBZA.F | $39.05 42.69 USD |
-1.26
|
$2.15B 2.35B USD | $7.99K 8.73K USD | $38.8 42.41 USD | $40.25 44 USD | $2.15B 2.35B USD | 15.93 | $2.45 2.68 USD | |
| 3SBio Inc. 83B.F | $0.8599 0.93 USD |
-3.39
|
$2.11B 2.31B USD | $0 0 USD | $0.8599 0.93 USD | $0.8599 0.93 USD | $2.11B 2.31B USD | 9.50 | $0.09 0.1 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $110 120.24 USD |
0
|
$2.08B 2.28B USD | $20 21.86 USD | $110 120.24 USD | $117 127.9 USD | $2.08B 2.28B USD | 0 | -$0.21 -0.2 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| ImmunityBio, Inc. 26CA.F | $2.7 2.95 USD |
-14.3
|
$1.97B 2.15B USD | $5.08K 5.55K USD | $2.7 2.95 USD | $3.18 3.48 USD | $1.97B 2.15B USD | 0 | -$0.87 -0.9 USD | |
| Mesoblast Limited LWB.F | $1.45 1.59 USD |
+4.32
|
$1.97B 2.15B USD | $1.05K 1.15K USD | $1.45 1.59 USD | $1.45 1.59 USD | $1.97B 2.15B USD | 0 | -$0.17 -0.1 USD | |
| Everest Medicines Limited 6HN.F | $5.8 6.34 USD |
+2.65
|
$1.94B 2.12B USD | $100 109.31 USD | $5.8 6.34 USD | $5.8 6.34 USD | $1.94B 2.12B USD | 0 | -$0.43 -0.4 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $33.8 36.95 USD |
+3.05
|
$1.94B 2.12B USD | $60 65.59 USD | $33.8 36.95 USD | $33.8 36.95 USD | $1.94B 2.12B USD | 3.01 | $11.2 12.24 USD | |
| Centessa Pharmaceuticals plc 260.F | $14.4 15.74 USD |
+1.41
|
$1.92B 2.1B USD | $0 0 USD | $14.4 15.74 USD | $14.8 16.18 USD | $1.92B 2.1B USD | 0 | -$1.46 -1.5 USD | |
| BioArctic AB (publ) B9A.F | $20.34 22.23 USD |
-4.51
|
$1.84B 2.01B USD | $1.1K 1.2K USD | $20.34 22.23 USD | $21.6 23.61 USD | $1.84B 2.01B USD | 0 | -$0.18 -0.1 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $19.9 21.75 USD |
+3.65
|
$1.75B 1.91B USD | $95 103.85 USD | $19.6 21.43 USD | $19.9 21.75 USD | $1.75B 1.91B USD | 0 | -$3.23 -3.5 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $8.23 9 USD |
+1.6
|
$1.72B 1.88B USD | $100 109.31 USD | $8.23 9 USD | $8.23 9 USD | $1.72B 1.88B USD | 0 | -$0.41 -0.4 USD | |
| Pharma Mar, S.A. PMRA.F | $95.75 104.67 USD |
+1.43
|
$1.7B 1.86B USD | $61 66.68 USD | $95.75 104.67 USD | $95.75 104.67 USD | $1.7B 1.86B USD | 2393.75 | $0.04 0.04 USD | |
| Ascentage Pharma Group International 36X.F | $4.42 4.83 USD |
0
|
$1.69B 1.85B USD | $50 54.66 USD | $4.42 4.83 USD | $4.6 5.03 USD | $1.69B 1.85B USD | 0 | -$0.17 -0.1 USD | |
| Bavarian Nordic A/S BV3.F | $21.46 23.46 USD |
-5.17
|
$1.69B 1.85B USD | $1.99K 2.18K USD | $21.46 23.46 USD | $22.95 25.09 USD | $1.69B 1.85B USD | 11.06 | $1.94 2.12 USD | |
| Galapagos NV GXEA.F | $25 27.33 USD |
0
|
$1.68B 1.84B USD | $4 4.37 USD | $25 27.33 USD | $25 27.33 USD | $1.68B 1.84B USD | 0 | -$0.02 -0.02 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $3.24 3.54 USD |
0
|
$1.66B 1.81B USD | $196 214.25 USD | $3.24 3.54 USD | $3.24 3.54 USD | $1.66B 1.81B USD | 13.50 | $0.24 0.26 USD | |
| Galapagos NV GXE.F | $24.42 26.69 USD |
-2.48
|
$1.64B 1.79B USD | $200 218.63 USD | $24.42 26.69 USD | $24.98 27.31 USD | $1.64B 1.79B USD | 0 | -$0.02 -0.02 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $18 19.68 USD |
-4.26
|
$1.62B 1.77B USD | $0 0 USD | $18 19.68 USD | $19.3 21.1 USD | $1.62B 1.77B USD | 0 | -$3.23 -3.5 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $3.87 4.23 USD |
-2.32
|
$1.61B 1.76B USD | $565 617.62 USD | $3.87 4.23 USD | $4.08 4.46 USD | $1.61B 1.76B USD | 0 | -$1.23 -1.3 USD | |
| MannKind Corporation NNFN.F | $5.07 5.55 USD |
+3.03
|
$1.56B 1.7B USD | $537 587.01 USD | $5.07 5.55 USD | $5.07 5.55 USD | $1.56B 1.7B USD | 50.73 | $0.1 0.11 USD | |
| Wave Life Sciences Ltd. 1U5.F | $9.85 10.77 USD |
0
|
$1.54B 1.68B USD | $200 218.63 USD | $9.85 10.77 USD | $9.85 10.77 USD | $1.54B 1.68B USD | 0 | -$1.08 -1.1 USD | |
| Genus plc GBE.F | $21.8 23.83 USD |
+5.83
|
$1.47B 1.61B USD | $19 20.77 USD | $21.8 23.83 USD | $22 24.05 USD | $1.47B 1.61B USD | 0 | -$0.07 -0.07 USD | |
| Biotest Aktiengesellschaft BIO3.F | $28.9 31.59 USD |
-0.34
|
$1.39B 1.52B USD | $100 109.31 USD | $28.9 31.59 USD | $28.9 31.59 USD | $1.39B 1.52B USD | 16.70 | $1.73 1.89 USD | |
| Biotest Aktiengesellschaft BIO.DE | $41 44.82 USD |
-0.49
|
$1.39B 1.52B USD | $870 951.03 USD | $41 44.82 USD | $41 44.82 USD | $1.39B 1.52B USD | 23.69 | $1.73 1.89 USD | |
| Biotest Aktiengesellschaft BIO.F | $40.6 44.38 USD |
-0.49
|
$1.39B 1.52B USD | $70 76.52 USD | $40.6 44.38 USD | $40.6 44.38 USD | $1.39B 1.52B USD | 23.46 | $1.73 1.89 USD | |
| Immunocore Holdings plc 6YG.F | $27.2 29.73 USD |
-2.86
|
$1.37B 1.5B USD | $0 0 USD | $27 29.51 USD | $27.8 30.39 USD | $1.37B 1.5B USD | 0 | -$0.98 -1.07 USD | |
| Immunocore Holdings plc 6YG.MU | $27 29.51 USD |
-4.93
|
$1.35B 1.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.35B 1.48B USD | 0 | -$1.32 -1.4 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $19.7 21.53 USD |
+2.07
|
$1.31B 1.43B USD | $200 218.63 USD | $19.7 21.53 USD | $19.7 21.53 USD | $1.31B 1.43B USD | 0 | -$2.36 -2.5 USD | |
| Raspberry Pi Holdings PLC R 0IK.F | $6.9 7.54 USD |
-5.48
|
$1.28B 1.4B USD | $400 437.25 USD | $6.9 7.54 USD | $7.25 7.93 USD | $1.28B 1.4B USD | 43.12 | $0.16 0.17 USD | |
| Lexicon Pharmaceuticals, Inc. LX31.MU | $3.53 3.86 USD |
0
|
$1.28B 1.39B USD | $250 273.28 USD | $3.53 3.86 USD | $3.53 3.86 USD | $1.28B 1.39B USD | 0 | -$0.55 -0.6 USD | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $14.7 16.07 USD |
+2.08
|
$1.27B 1.39B USD | $71 77.61 USD | $14.7 16.07 USD | $14.7 16.07 USD | $1.27B 1.39B USD | 0 | -$3.5 -3.8 USD | |
| Liquidia Corporation LT4.MU | $14.86 16.24 USD |
0
|
$1.26B 1.37B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.26B 1.37B USD | 0 | -$1.56 -1.7 USD | |
| Liquidia Corporation LT4.F | $14.76 16.13 USD |
+0.75
|
$1.25B 1.37B USD | $327 357.46 USD | $14.76 16.13 USD | $14.76 16.13 USD | $1.25B 1.37B USD | 0 | -$1.56 -1.7 USD | |
| Novavax, Inc. NVV1.F | $7.76 8.48 USD |
-3.46
|
$1.25B 1.36B USD | $4.9K 5.35K USD | $7.76 8.48 USD | $8.1 8.86 USD | $1.25B 1.36B USD | 0 | -$2.1 -2.2 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.28 1.4 USD |
-2.73
|
$1.23B 1.34B USD | $6.7K 7.32K USD | $1.28 1.4 USD | $1.34 1.46 USD | $1.23B 1.34B USD | 0 | -$0.24 -0.2 USD | |
| Ardelyx, Inc. 41X.F | $5.09 5.57 USD |
+2.66
|
$1.22B 1.33B USD | $4.65K 5.08K USD | $5.09 5.57 USD | $5.09 5.57 USD | $1.22B 1.33B USD | 0 | -$0.16 -0.1 USD | |
| Viridian Therapeutics, Inc. 1S1.F | $14.6 15.96 USD |
+1.39
|
$1.2B 1.31B USD | $137 149.76 USD | $14.6 15.96 USD | $14.6 15.96 USD | $1.2B 1.31B USD | 0 | -$4.16 -4.5 USD | |
| Liquidia Corporation LT4.SG | $14.06 15.37 USD |
-3.76
|
$1.19B 1.3B USD | $0 0 USD | $14.06 15.37 USD | $14.79 16.17 USD | $1.19B 1.3B USD | 0 | -$1.56 -1.7 USD | |
| Adaptive Biotechnologies Corporation 1HM.MU | $7.98 8.73 USD |
0
|
$1.18B 1.29B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.18B 1.29B USD | 0 | -$1.04 -1.1 USD | |
| Adaptive Biotechnologies Corporation 1HM.F | $7.83 8.56 USD |
+1.08
|
$1.16B 1.27B USD | $631 689.77 USD | $7.83 8.56 USD | $7.83 8.56 USD | $1.16B 1.27B USD | 0 | -$1.04 -1.1 USD | |
| GNI Group Ltd. 3G6.F | $21.2 23.17 USD |
0
|
$1.11B 1.21B USD | $39 42.63 USD | $21.2 23.17 USD | $21.2 23.17 USD | $1.11B 1.21B USD | 176.66 | $0.12 0.13 USD | |
| Ocular Therapeutix, Inc. 0OT.F | $6.79 7.42 USD |
+3.13
|
$1.07B 1.17B USD | $150 163.97 USD | $6.79 7.42 USD | $6.79 7.42 USD | $1.07B 1.17B USD | 0 | -$1.24 -1.3 USD | |
| Geron Corporation GON.F | $1.68 1.83 USD |
+0.96
|
$1.07B 1.17B USD | $700 765.19 USD | $1.68 1.83 USD | $1.68 1.83 USD | $1.07B 1.17B USD | 0 | -$0.26 -0.2 USD | |
| Innoviva, Inc. HVE.F | $16.9 18.47 USD |
-1.74
|
$1.06B 1.16B USD | $211 230.65 USD | $16.9 18.47 USD | $17.1 18.69 USD | $1.06B 1.16B USD | 48.28 | $0.35 0.38 USD | |
| Xencor, Inc. XE9.F | $14.5 15.85 USD |
+2.84
|
$1.03B 1.13B USD | $415 453.65 USD | $14.5 15.85 USD | $14.5 15.85 USD | $1.03B 1.13B USD | 0 | -$3.44 -3.7 USD | |
| Aurinia Pharmaceuticals Inc. IKAP.F | $7.51 8.21 USD |
+0.4
|
$1.03B 1.13B USD | $400 437.25 USD | $7.47 8.16 USD | $7.51 8.21 USD | $1.03B 1.13B USD | 187.84 | $0.04 0.04 USD | |
| Intellia Therapeutics, Inc. 38I.F | $9.32 10.19 USD |
-6.33
|
$1B 1.1B USD | $485 530.17 USD | $9.32 10.19 USD | $9.32 10.19 USD | $1B 1.1B USD | 0 | -$5.05 -5.5 USD | |
| Replimune Group, Inc. 7R8.F | $12.7 13.88 USD |
+5.83
|
$981.83M 1.07B USD | $158 172.72 USD | $12.1 13.23 USD | $12.7 13.88 USD | $981.83M 1.07B USD | 0 | -$2.95 -3.2 USD | |
| Calliditas Therapeutics AB (publ) LC8A.F | $35 38.26 USD |
0
|
$973.33M 1.06B USD | $0 0 USD | $0 0 USD | $0 0 USD | $973.33M 1.06B USD | 0 | $0 0 USD | |
| Calliditas Therapeutics AB (publ) LC8.F | $17.83 19.49 USD |
0
|
$963.42M 1.05B USD | $0 0 USD | $0 0 USD | $0 0 USD | $963.42M 1.05B USD | 0 | $0 0 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $8.73 9.54 USD |
+0.53
|
$960.65M 1.05B USD | $15 16.4 USD | $8.73 9.54 USD | $8.73 9.54 USD | $960.65M 1.05B USD | 0 | -$2.63 -2.8 USD | |
| Cerus Corporation CU2.DE | $5.14 5.62 USD |
0
|
$942.01M 1.03B USD | $0 0 USD | $0 0 USD | $0 0 USD | $942.01M 1.03B USD | 0 | $0 0 USD | |
| Poseida Therapeutics, Inc. 2RZ.F | $9.05 9.89 USD |
0
|
$895.18M 978.56M USD | $0 0 USD | $0 0 USD | $0 0 USD | $895.18M 978.56M USD | 0 | $0 0 USD | |
| Sangamo Therapeutics, Inc. GBY.DE | $5.05 5.52 USD |
0
|
$884.7M 967.1M USD | $0 0 USD | $0 0 USD | $0 0 USD | $884.7M 967.1M USD | 0 | $0 0 USD | |
| Pharvaris N.V. 9EN.F | $14.6 15.96 USD |
-2.67
|
$791.8M 865.55M USD | $200 218.63 USD | $14.2 15.52 USD | $15 16.4 USD | $791.8M 865.55M USD | 0 | -$2.6 -2.8 USD | |
| Ergomed plc 2EM.F | $14.68 16.05 USD |
0
|
$788.59M 862.04M USD | $0 0 USD | $0 0 USD | $0 0 USD | $788.59M 862.04M USD | 0 | $0 0 USD | |
| Ascletis Pharma Inc. 2VJ.F | $0.54 0.58 USD |
0
|
$776.4M 848.71M USD | $584 638.39 USD | $0.54 0.58 USD | $0.56 0.61 USD | $776.4M 848.71M USD | 0 | -$0.03 -0.03 USD | |
| AbCellera Biologics Inc. 8QQ.F | $2.3 2.51 USD |
-7.78
|
$765.03M 836.28M USD | $7K 7.65K USD | $2.3 2.51 USD | $2.48 2.71 USD | $765.03M 836.28M USD | 0 | -$0.53 -0.5 USD | |
| Intercept Pharmaceuticals, Inc. I4P.F | $17.52 19.15 USD |
0
|
$738.99M 807.82M USD | $0 0 USD | $0 0 USD | $0 0 USD | $738.99M 807.82M USD | 0 | $0 0 USD | |
| Prothena Corporation plc 0PT.F | $13.7 14.98 USD |
-8.67
|
$737.43M 806.11M USD | $30 32.79 USD | $13.7 14.98 USD | $15.2 16.62 USD | $737.43M 806.11M USD | 0 | -$2.18 -2.3 USD | |
| Bicycle Therapeutics plc 50BA.F | $10.1 11.04 USD |
0
|
$727.72M 795.49M USD | $30 32.79 USD | $10.1 11.04 USD | $10.2 11.15 USD | $727.72M 795.49M USD | 0 | -$2.79 -3.04 USD | |
| Opthea Limited UKJ.F | $0.55 0.6 USD |
+0.92
|
$698.8M 763.88M USD | $16 17.49 USD | $0.55 0.6 USD | $0.55 0.6 USD | $698.8M 763.88M USD | 0 | -$0.33 -0.3 USD | |
| Opthea Limited UKJ2.F | $4.36 4.77 USD |
-0.46
|
$689.28M 753.48M USD | $0 0 USD | $4.24 4.63 USD | $4.36 4.77 USD | $689.28M 753.48M USD | 0 | -$2.66 -2.9 USD | |
| uniQure N.V. UQ1.F | $12.47 13.63 USD |
+8.96
|
$678.03M 741.18M USD | $90 98.38 USD | $12.47 13.63 USD | $12.47 13.63 USD | $678.03M 741.18M USD | 0 | -$4.76 -5.2 USD | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $2.86 3.13 USD |
-7.74
|
$677.45M 740.55M USD | $1.15K 1.26K USD | $2.84 3.1 USD | $3.06 3.34 USD | $677.45M 740.55M USD | 0 | -$1.61 -1.7 USD | |
| Anavex Life Sciences Corp. 12X1.F | $7.8 8.52 USD |
+4.92
|
$667.98M 730.19M USD | $1.5K 1.64K USD | $7.8 8.52 USD | $7.8 8.52 USD | $667.98M 730.19M USD | 0 | -$0.53 -0.5 USD | |
| Takara Bio Inc. TF2.F | $5.05 5.52 USD |
-0.98
|
$662.02M 723.68M USD | $200 218.63 USD | $5.05 5.52 USD | $5.15 5.63 USD | $662.02M 723.68M USD | 0 | $0 0 USD | |
| Capricor Therapeutics, Inc. 4LN2.F | $13.98 15.28 USD |
+6.07
|
$661.21M 722.79M USD | $284 310.45 USD | $13.98 15.28 USD | $14.44 15.78 USD | $661.21M 722.79M USD | 0 | -$0.98 -1.07 USD | |
| Arbutus Biopharma Corporation I9DN.F | $3.28 3.59 USD |
+3.14
|
$627.94M 686.42M USD | $110 120.24 USD | $3.28 3.59 USD | $3.28 3.59 USD | $627.94M 686.42M USD | 0 | -$0.41 -0.4 USD | |
| Pharming Group N.V. PHG.F | $8.55 9.35 USD |
+1.18
|
$610.88M 667.77M USD | $1.17K 1.28K USD | $7.9 8.64 USD | $8.55 9.35 USD | $610.88M 667.77M USD | 0 | -$0.26 -0.2 USD | |
| CorMedix Inc. 19KA.F | $9.85 10.77 USD |
+1.03
|
$599.03M 654.82M USD | $948 1.04K USD | $9.85 10.77 USD | $9.85 10.77 USD | $599.03M 654.82M USD | 0 | -$0.77 -0.8 USD | |
| GH Research PLC 1KA.F | $9.35 10.22 USD |
-5.08
|
$597.83M 653.51M USD | $7 7.65 USD | $9.35 10.22 USD | $9.35 10.22 USD | $597.83M 653.51M USD | 0 | -$0.72 -0.7 USD | |
| CK Life Sciences Int'l., (Holdings) Inc. LSI.F | $0.05999 0.06 USD |
-0.89
|
$595.8M 651.29M USD | $0 0 USD | $0.05999 0.06 USD | $0.05999 0.06 USD | $595.8M 651.29M USD | 0 | $0 0 USD | |
| Pharming Group N.V. PHGN.F | $0.8699 0.95 USD |
-1.76
|
$593.11M 648.35M USD | $10 10.93 USD | $0.8699 0.95 USD | $0.8699 0.95 USD | $593.11M 648.35M USD | 0 | -$0.03 -0.03 USD | |
| Abbisko Cayman Limited 8ZD.F | $0.8199 0.89 USD |
+15.6
|
$575.35M 628.93M USD | $7K 7.65K USD | $0.7399 0.81 USD | $0.8199 0.89 USD | $575.35M 628.93M USD | 0 | $0 0 USD | |
| Kura Oncology, Inc. KUR.F | $7.33 8.01 USD |
+1.05
|
$573.1M 626.47M USD | $135 147.57 USD | $7.33 8.01 USD | $7.33 8.01 USD | $573.1M 626.47M USD | 0 | -$1.94 -2.1 USD | |
| Valneva SE AYJ0.F | $6.5 7.11 USD |
-1.52
|
$569.69M 622.75M USD | $30 32.79 USD | $6.5 7.11 USD | $6.65 7.27 USD | $569.69M 622.75M USD | 0 | -$0.12 -0.1 USD | |
| Xeris Biopharma Holdings, Inc. 2B30.F | $3.62 3.96 USD |
+1.74
|
$543.72M 594.36M USD | $1.29K 1.41K USD | $3.62 3.96 USD | $3.62 3.96 USD | $543.72M 594.36M USD | 0 | -$0.41 -0.4 USD | |
| KalVista Pharmaceuticals, Inc. 4XC1.F | $10.8 11.81 USD |
+6.93
|
$538.56M 588.71M USD | $67 73.24 USD | $10.8 11.81 USD | $10.8 11.81 USD | $538.56M 588.71M USD | 0 | -$3.54 -3.8 USD | |
| ORIC Pharmaceuticals, Inc. 4TZ.F | $7.5 8.2 USD |
+1.35
|
$538.06M 588.18M USD | $790 863.58 USD | $7.5 8.2 USD | $7.55 8.25 USD | $538.06M 588.18M USD | 0 | -$1.76 -1.9 USD | |
| Nxera Pharma Co., Ltd. JSS.F | $5.7 6.23 USD |
+6.54
|
$535.49M 585.36M USD | $10 10.93 USD | $5.7 6.23 USD | $5.7 6.23 USD | $535.49M 585.36M USD | 0 | -$0.35 -0.3 USD | |
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
||||||||||